General Information
General procedures. All reactions were run under an atmosphere of argon unless otherwise indicated. Room temperature refers to 22 °C, ambient pressure to 1013 hPa.
Reagents and anhydrous solvents were transferred via oven-dried syringes and cannulae.
Flasks were flame-dried under vacuum and cooled under a constant stream of argon.
Tetrahydrofuran was distilled from potassium under argon, dichloromethane from SICAPENT (phosphorus pentoxide on solid support with indicator), ethanol from magnesium ethoxide and triethylamine from calcium hydride. Methanol, toluene, acetone, dimethylformamide,
S3
acetonitrile and pyridine were purchased from Acros or Sigma-Aldrich (anhydrous over molecular sieves).
All other chemicals were purchased from ABCR, Acros, Sigma-Aldrich, Alfa Aesar, Fluorochem, Merck and TCI Europe at the highest commercially available purity and used as such.
Reactions were monitored by thin-layer chromatography using Merck silica gel 60 F 254 TLC aluminium sheets and visualized with ceric ammonium molybdate, potassium permanganate or vanillin staining solution. Chromatographic purification was performed as flash chromatography on Merck silica gel 40-63 µm, 60 Å, using a forced flow of eluent (method of Still). Concentration under reduced pressure was performed by rotary evaporation at 40 °C at the appropriate pressure.
Yields refer to chromatographically purified and spectroscopically pure compounds.
NMR spectra were recorded on a Bruker Avance 700 (operating at 700 MHz for Where 2D-spectra were recorded and allowed complete assignment of all hydrogen and carbon-atoms of a compound, spectral data include this assignment using common steroid numbering. Where this is not the case, all hydrogen signals below 2 ppm are omitted and only methyl groups and isolated signals in this range are listed. All spectra can be found as copies at the end of the experimental section.
High resolution mass spectra were obtained on a Bruker Daltonics ESI-FT-ICR-MS APEX II. (1.1 L) at room temperature was sequentially added 3,4-dihydro-2H-pyran (55.0 mL, 604.0 mmol, 2.7 equiv.) and pyridinium para-toluenesulfonate (3.48 g, 13.9 mmol, 0.05 equiv.). After stirring for 2.5 h the mixture was quenched with water (400 mL). The phases were separated, the aqueous layer was extracted with CH 2 Cl 2 (2 x 300 mL) and the combined organic phases were dried (MgSO 4 ). All volatiles were removed under reduced pressure to give crude title compound (84.5 g, 227.0 mmol, quant.; mixture of diastereoisomers) as a colorless solid which was used in the next step without further purification. 170.6, 140.1, 122.0, 73.9, 51.8, 50.3, 47.7, 38.2, 37.1, 36.9, 35.9, 31.6, 31.5, 30.9, 27.8, 22.0, 21.6, 20.5, 19.5, 13.7 0, 160.6, 149.0, 141.5, 141.3, 121.6, 121.1, 97.0, 76.0, 63.0, 58.1, 53.4, 50.7, 45.7, 40.4, 38.9, 37.5, 37.3, 37.1, 34.2, 31.7, 31.4, 29.8, 28.1, 25.6, 23.4, 20.8, 20.1, 19.5, 16.3 (2.0 L, 1:2:1), the layers were separated and the organic layer was washed with aqueous ammonia (25%, 2 x 300 mL) and saturated brine (150 mL), dried (Na 2 SO 4 ) and the solvents were removed under reduced pressure. The residue was redissolved in MeOH/AcOH (600 mL, 1:1) and heated to 90°C for 6 h. The solvents were removed under reduced pressure and the residue was partitioned between EtOAc (1.3 L) and saturated brine (200 mL). The 2, 52.8, 51.0, 50.6, 42.9, 38.4, 37.8, 36.5, 32.2, 31.7, 31.4, 30.4, 22.4, 19.8, 8.4 
(-)-3,12-bis(Triethylsilyloxy)-androst-5-ene-17-one (17) :
To a solution of diol 6 (6.00 g, 19.7 mmol, 1.0 equiv.) and 2,6-lutidine (9.2 mL, 78.8 mmol,
4.0 equiv.) in CH 2 Cl 2 (800 mL) at 0 °C was added dropwise triethylsilyl trifluoromethanesulfonate (9.8 mL, 43.4 mmol, 2.2 equiv.) over a period of 45 min. After 3 h at the same temperature another portion of triethylsilyl trifluoromethanesulfonate (2.3 mL, 10.0 S7 mmol, 0.5 equiv.) was added and the mixture was stirred for an additional 1 h. 141.8, 120.6, 72.3, 72.2, 52.0, 50.4, 49.4, 42.9, 37.5, 36.8, 35.8, 32.2, 31.7, 30.6, 30.5, 21.2, 19.5, 8.4, 7.2, 7.0, 6.9, 6.6, 5.7, 5.4, 5. 3.5 (-)-3-Hydroxy-12-(triethylsilyloxy)androst-5-ene-17-one (7):
To a solution of HF•pyridine complex (70% HF, 30% pyridine, 3.6 mL) in pyridine (22 mL  max 3435, 2955, 2875, 1742, 1458, 1240, 1102, 1054, 825, 742 cm 121.0, 72.1, 71.7, 51.9, 50.4, 49.2, 42.3, 37.3, 36.7, 35.8, 31.7, 31.7, 30.6, 30.5, 21.2, 19.5, 8.4, 7.1, 5.3 3.7 (+)-3,5-Cyclo-5-6-methoxy-12-triethylsilyloxy-androstane-17-one (8):
A flask containing potassium acetate (8.50 g, 86.8 mmol, 7.0 equiv.) was dried under vacuum (0.7 mbar) at 120 °C for 24 h. It was allowed to cool to room temperature and a solution of tosylate 18 (7.10 g, 12.4 mmol, 1.0 equiv.) in MeOH (230 mL) was added. The reaction mixture was heated to 64 °C for 1.5 h. The mixture was allowed to cool to room temperature, water (100 mL) was added and the mixture was extracted with EtOAc (3 x 500 mL). The combined organic layers were washed with saturated brine (100 mL), dried (MgSO 4 ) and concentrated under reduced pressure The soobtained crude product was purified by column chromatography (SiO 2 , n-hexane/EtOAc; 8, 52.5, 50.1, 46.6, 43.5, 35.8, 35.0, 33.9, 33.5, 33.1, 29.4, 25.0, 21.3, 21.0, 19.3, 13.3, 8.7, 7.1, 5.3 and the reaction mixture was stirred for 1 h. The cooling bath was removed and the mixture was stirred for 15 min while warming to room temperature. Afterwards, the reaction mixture was cooled to -10 °C and a solution of N-phenyl-bis-(trifluoromethane sulfonimide) (14.50 g, 40.6 mmol, 1.7 equiv.) in THF (50 mL) was added dropwise. The reaction mixture was stirred for 20 min at -10 °C at which time it was partitioned between water (50 mL) and EtOAc (250 mL). The aqueous layer was separated and extracted with EtOAc (3 x 300 mL), the combined organic layers were washed with saturated brine (250 mL), dried (MgSO 4 ) and all volatiles were removed under reduced pressure. The so-obtained crude product was purified by column chromatography (SiO 2 , n- 56.7, 51.8, 50.8, 47.4, 43.8, 35.4, 34.1, 33.5, 32.9, 27.9, 27.8, 25.1, 21.3, 19.3, 13.4, 11.3, 7.3, 6 4, 161.2, 160.7, 139.3, 122.8, 81.6, 73.8, 54.6, 49.7, 49.4, 45.4, 38.0, 37.0, 36.9, 33.2, 31.5, 31.0, 28.4, 27.7, 27.2, 27.1, 24.3, 19.3, 8.3 3.14 (-)-3-Acetoxypregn-5-ene-21,12-carbolactone (25) To a solution of the dihydroxycarboxylic acid 21 (250 mg, 0.69 mmol) in pyridine (8 mL 2945, 1773, 1723, 1606, 1467, 1440, 1366, 1248, 1194, 1168, 1034, 788, 763 cm 4, 170.7, 139.7, 122.2, 84.5, 73.7, 54.5, 54.0, 49.4, 45.3, 38.1, 37.1, S13 36.8, 31.1, 30.4, 27.8, 27.5, 26.7, 23.8, 23.1, 21.6, 21.5, 19.4, 7.0 195.2, 161.1, 160.7, 139.3, 122.8, 81.5, 73.7, 54.6, 49.9, 49.4, 45.5, 38.0, 37.0, 36.9, 31.5, 30.9, 28.5, 27.7, 27.6, 27.3, 24.3 160.7, 139.3, 122.8, 81.5, 73.7, 54.6, 49.9, 49.4, 45.6, 38.0, 37.3, 37.0, 36.9, 31.6, 31.5, 30.9, 28.6, 27.7, 27.3, 24.3 
(-)-(17R)-spiro[312-Diformyloxyandrost-5-ene-17,3'-cyclopenta-1'-one] (11):
A suspension of rhodium(II) acetate dimer (6.2 mg, 14 mol, 0.07 equiv.) in CH 2 Cl 2 (3 mL) was degassed three times using freeze-and-thaw cycles. The resulting green suspension was heated to 41 °C and a solution of diazoketone 3 (88 mg, 0.20 mmol, 1.0 equiv.) in degassed CH 2 Cl 2 (2.5 mL) was added dropwise. The mixture was kept at this temperature for 2 h, allowed to cool to room temperature, and all volatiles were removed under reduced pressure to obtain the crude product which was purified by column chromatography (SiO 2 , n-hexane/EtOAc; 5:1, v/v) to give pure title compound (43 mg, 0.104 mmol, 52%) as colorless crystals. 5, 160.6, 160.6, 139.2, 122.7, 76.7, 73.6, 53.6, 52.4, 48.9, 47.5, 47.1, 38.0, 37.3, 37.0, 36.8, 36.3, 32.8, 31.6, 31.5, 27.6, 27.1, 24.3, 19.3, 10.3 6, 140.8, 121.6, 74.7, 71.7, 53.6, 52.5, 49.4, 48.2, 47.9, 42.2, 37.5, 37.4, 36.7, 36.4, 33.1, 31.7, 31.6, 31.6, 31.4, 27.3, 19.5, 9 3435, 2932, 2901, 2857, 1731, 1634, 1472, 1254, 1095, 888, 872, 837, 775 cm 3, 141.4, 121.0, 74.7, 72.6, 53.7, 52.5, 49.5, 48.2, 48.0, 42.8, 37.5, 37.5, 36.8, 36.4, 33.2, 32.1, 31.7, 31.6, 31.5, 26.0, 24.8, 19.5, 18.4, 9.2, -4.5 To remove the minor isomer, the mixture was dissolved in EtOAc (4 mL) and rhodium on carbon (10%, 12 mg, 12 mol, 0.07 equiv.) was added. 142.6, 140.9, 126.7, 121.5, 72.8, 52.5, 51.1, 49.4, 44.4, 42.5, 42.4, 38.5, 36.8, 36.2, 35.7, 32.0, 31.7, 31.1, 29.0, 26.1, 24.4, 19.8, 18.4, 13.9, -4.4 8, 147.5, 142.6, 139.7, 136.3, 132.6, 128.0, 121.5, 121.3, 72.8, 52.6, 49.5, 46.8, 43.2, 42.6, 42.5, 38.5, 38.5, 36.8, 32.0, 31.2, 28.8, 26.1, 24.9, 18.9, 18.4, 14.7, -4.4 
Carbacyclopamine analog 2:
To a solution of silylether 23 (6.0 mg, 12.0 mol, 1.0 equiv.) in THF (0.5 mL) at room temperature was added tetrabutylammonium fluoride (1.0 M in THF, 36 µL, 36 mol, 3.0 equiv.) and the reaction mixture was stirred for 10 h. After this time water (3 mL) was added and the mixture was extracted with CH 2 Cl 2 (3 x 5 mL). The combined organic layers were dried (MgSO 4 ), all volatiles were removed under reduced pressure and the so-obtained crude product was purified by column chromatography (SiO 2 , CHCl 3 + 3% MeOH) to give the title compound in ca. 90% purity judged by 3420, 2929, 2875, 2854, 1733, 1716, 1457, 1436, 1384, 1260, 1092, 
Acid Stability
To a solution of carbacyclopamine analog 2 (2.0 mg, 5.5 mol) in THF (0.5 mL) was 
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Biochemistry
The interference of the carbacyclopamine analog 2 with the hedgehog signaling pathway 
Luciferase reporter assay
Incubation of cells. For performing the assay, Shh-LIGHTII cells were grown to reach 80% confluence, washed twice with Versene, detached with 2 mL trypsin for not longer than 2 min and resuspended in 8 mL of growth medium. After centrifugation for 3 min, the supernatant was removed and the cell pellet dissolved in approximately 10 mL of growth medium. Finally, 20,000 to 100,000 cells per well were cultured in a 24-well plate for 48 h. For exposure to the analog the growth medium was removed and the cells were exposed to the compound in 500 μL/well incubation medium for 48 h. Stock solutions were prepared in EtOH and introduced in different concentrations into the incubation medium to reach a final solvent concentration of 0.05%. Due to the assay principle, Shh-LIGHTII cells had to be co-exposed to 100 nM of SAG (Smoothened agonist) for determining the inhibitory activity of the compounds. A SAG stock solution was prepared in EtOH and introduced into the medium. The final EtOHconcentration -introduced by SAG and the test compound -was 0.1%. As a positive control a 100 nM SAG solution in incubation medium (0.1% EtOH) was used, negative controls were treated with EtOH only.
